September is National Prostate Cancer Awareness Month, and Reno CyberKnife encourages men seeking prostate cancer treatment to educate themselves on the range of options available to treat the disease.
Did you know? September is Prostate Cancer Awareness Month645 North Arlington Ave Suite 120 Reno, NV 89503 (775) 348-‐9900 www.renocyberknife.com
Did you know? The American Cancer Society esLmates 241,740 new prostate cancer diagnoses in 2012. Quick stats: • 1 in 6 men will be diagnosed with prostate cancer during his life:me. • Prostate cancer occurs mainly in older men. Nearly two thirds of cases are diagnosed in men aged 65 or above, and it is rare before age 40. The average age at the :me of diagnosis is about 67. • More than 2.5 million men in the United States who have been diagnosed with prostate cancer at some point are s:ll alive today, thanks to advancements in treatment. 645 North Arlington Ave Suite 120 Reno, NV 89503 (775) 348-‐9900 www.renocyberknife.com
Did you know? CyberKnife can noninvasively treat prostate cancer in ﬁve or fewer treatment sessions. How it works: • CyberKnife treats prostate cancer with a procedure called stereotac:c body radia:on therapy, a noninvasive method of trea:ng tumors with precisely targeted high-‐dose radia:on. The result is greatly increased accuracy that spares healthy Lssue. • Prior to treatment, small metal :ssue markers known as ﬁducials are implanted in the prostate to help the CyberKnife pinpoint the tumor loca:on throughout each treatment, ensuring the radiaLon beams delivered during treatment are always locked on the tumor. • Pa:ents are then scheduled for no more than ﬁve CyberKnife treatments. Each treatment takes about 30 -‐ 40 minutes, and paLents can return to their normal rouLnes following each procedure. • In recent years, CyberKnife has gained awareness among prostate cancer pa:ents in par:cular. Many men are drawn to the convenience of shorter treatment and fewer side eﬀects. 645 North Arlington Ave Suite 120 Reno, NV 89503 (775) 348-‐9900 www.renocyberknife.com
Our Center Opened in 2008, Reno CyberKnife is a service of Saint Mary’s Regional Medical Center and provides the only CyberKnife technology in northern Nevada. Dr. Jonathan Tay is the medical director of Reno CyberKnife. He is an active clinical investigator and has conducted research on prostate cancer and treatments for prostate cancer. Under his leadership, Reno CyberKnife has developed cancer clinical trials and implemented a variety of prostate cancer therapies. Medical Director: Dr. Jonathan TayOther Resources645 North Arlington Ave Suite 120 Reno, NV 89503 (775) 348-‐9900 www.renocyberknife.com